Omeros OMER
NASDAQ OMER
$16.26 -0.29 (-1.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Omeros (OMER) Current Leases (2018)

Updated

Omeros' Current Leases was $889,000 in Q4 2018.

Analysis

Omeros (OMER) Current Leases (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Omeros 1.17 Bn 731.45 Mn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 889,000.00
API Access

Omeros Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=OMER&period=max&api_key=YOUR_API_KEY